Breaking News

PAREXEL CEO Named ACRO Chairman

January 10, 2013

von Rickenbach resumes role from 2005

The Association of Clinical Research Organizations (ACRO) has named PAREXEL chairman and chief executive officer, Josef von Rickenbach, as the organization’s 2013 chairman. ACRO is an advocate of CRO expertise in all aspects of clinical research and represents the CRO industry globally to sponsors, regulators and legislators, peer associations, academic organizations, patient groups, the media and the public.
 
"It is an honor to have been selected to lead ACRO's board of directors in 2013," said Mr. von Rickenbach. "As incoming chairman, I look forward to continuing the great momentum initiated by my predecessor to help ACRO and its members build and strengthen public understanding and confidence in clinical research. Equally, I welcome the opportunity to collaborate with the association's global stakeholders to promote the strategic value of clinical outsourcing, drive innovation in the drug development process and ensure the safe and ethical development of new medicines and treatments." 
 
In his role at PAREXEL, Mr. von Rickenbach was one of the first to define the clinical research services sector by making clinical development more effective for clients. He conceived a multidisciplinary and systems-oriented approach to outsourced clinical development, bringing efficiencies, scalability, and standardization to the process.
 
Mr. von Rickenbach previously served as chair of ACRO in 2005 and is a long-standing member of the ACRO board of directors.

blog comments powered by Disqus
  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important

  • Moore’s Law for More Health

    Moore’s Law for More Health

    Patrick Jordan , Encore Health Resources||June 2, 2015
    This year marks the semicentennial anniversary of a prediction about exponential growth and productivity